Unmet Needs in Glioblastoma Treatment: Key Drivers of Market Expansion | #imvax clinical trial # glioblastoma multiforme treatment market # glioblastoma multiforme market # glioblastoma treatment # glioblastoma multiforme survival rate # global glioblastoma market by end user # glioblastoma

Science and Technology

Unmet Needs in Glioblastoma Treatment: Key Drivers of Market Expansion

Glioblastoma Multiforme (GBM) is the most aggressive and lethal form of brain cancer, with limited treatment options and a poor prognosis. Despite advancements in cancer research, the survival rate for GBM remains low, highlighting the urgent need for innovative therapies. The increasing f